Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.

A Prescription Drug User Fee Act target date of February 1, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) ...

The Infusion Pump Market represents a critical segment within modern healthcare technology, enabling controlled and accurate ...

The elastomeric infusion pumps market is poised to grow from USD 1.15 billion in 2025 to USD 1.49 billion by 2030, at a CAGR of 5.3%. Increasing demand in oncology, pain management, anesthesia, and ...

Patients should receive training on the proper use of the delivery device prior to starting treatment. The Food and Drug Administration (FDA) has approved Onapgo™ (apomorphine hydrochloride [HCl]) for ...

InVera Medical announced recently that it picked up European approval for its minimally invasive device for delivering vein treatments.

Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.

Irish medtech company InVera Medical announced the CE Mark approval of its InVera Infusion Device. The device may now be marke ...

New devices address infusion delivery variability and expand the ICU Medical IV Performance Platform. Unlike traditional pumps that rely on specific setups and conditions for accurate delivery, ...

Questions about an infusion device have scuttled Supernus Pharmaceuticals’ attempt to win approval of a Parkinson’s disease therapy. The complete response letter marks the second time in two years ...